Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07344727 · ClinicalTrials.gov registry record · NA

Impact of Haskap Berries on Recovery From High Intensity Resistance Training

A NA study of Inflammation and Oxidative Stress, sponsored by Montana State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07344727: Recruiting NA study of Inflammation and Oxidative Stress, sponsored by Montana State University.

NCT07344727 is a NA study of Inflammation and Oxidative Stress that is actively recruiting participants, run by Montana State University. The registered enrollment target is 30 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07344727, a NA study of Inflammation and Oxidative Stress, is actively recruiting participants, sponsored by Montana State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following: * Do Haskaps speed the recovery of oxidative stress and inflammation markers after an intense lower body workout in resistance trained adults? * Do Haskaps speed the recovery of performance measures after an intense lower body workout in resistance trained adults? * The data collected in this investigation may also be used to ask additional questions not yet identified. For example, the investigators may use the stored samples to evaluate how the blood metabolites of participants differ before and after intense exercise. These additional questions are called secondary analyses. Please note that no genetic analysis will be conducted and racial and ethnic differences among participants will not be used in any secondary analyses. Researches will compare Haskap juice to a color, flavor and carbohydrate matched placebo to see if Haskaps speed recovery in inflammation, oxidative stress and performance. * Participants will be asked to drink either Haskap juice or placebo and follow a low polyphenolic diet * Participants will perform an intense resistance workout * Participants will have their blood drawn before and after the workout * Performance will be analyzed at 24, 48 and 72 hours after the workout

Primary Outcome

Maximal Voluntary Contraction (MVC) to assess force production of knee extensors at 60 degrees.

Interventions

  • DIETARY_SUPPLEMENT Placebo Comparator
  • DIETARY_SUPPLEMENT Haskap berry smoothie

Study Locations (1)

Montana

  • Montana State University - Bozeman

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-10-21
Est. Completion 2026-05
Phase NA
Montana State University

36 total trials

What NCT07344727 shows while recruiting

NCT07344727 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (90% lower).

The record links to 5 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Placebo Comparator is the first listed.

NCT07344727 reports a single indexed study location in Montana.

Frequently Asked Questions

What is clinical trial NCT07344727 about?

NCT07344727 is a clinical study titled "Impact of Haskap Berries on Recovery From High Intensity Resistance Training". The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following: * Do Haskaps speed ...

What is the current status of trial NCT07344727?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-21. Estimated completion is 2026-05.

What conditions does trial NCT07344727 study?

This clinical trial studies the following conditions: Inflammation, Oxidative Stress, Resistance Exercise, Recovery, Exercise Performance Recovery.

What interventions are being tested in trial NCT07344727?

The interventions under investigation include: Placebo Comparator (DIETARY_SUPPLEMENT), Haskap berry smoothie (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07344727?

This trial is sponsored by Montana State University, which has 36 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07344727 being conducted?

This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07344727's enrollment target sits among peer trials

30 98th of 132 higher than 27 of 132 other Inflammation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07344727, the US trial registry maintained by the National Library of Medicine. NCT07344727 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.